James P. Scanlan Attorney at Law Washington, DC, USA

Slides:



Advertisements
Similar presentations
2008 Joint Statistical Meetings Denver, Colorado, August 2-7, 2008 Evaluating the Size of Differences Between Group Rates in Settings of Different Overall.
Advertisements

American Public Health Association 138 th Annual Meeting Denver, Colorado Nov. 6-10, 2010 The Emerging European Acceptance of Scanlan’s Rule in Health.
The Misunderstood Relationship Between Declining Mortality and Increasing Racial and Social Disparities in Mortality Rates James P. Scanlan (Presented.
Worklessness, population health and health inequalities Frank Popham MRC SPHSU, Glasgow.
2009 Joint Statistical Meetings Washington, DC August 1-6, 2009 Interpreting Differential Effects in Light of Fundamental Statistical Tendencies James.
Measuring Health and Healthcare Disparities 2013 Research Conference of the Federal Committee on Statistical Methodology Washington, DC, Nov. 4-6, 2013.
Measurement Problems in the National Healthcare Disparities Report American Public Health Association 135 th Annual Meeting & Exposition, Nov. 3-7,2007,
Broad societal determinants of CVD and health Dubai 6/1/2006.
Population Health: Challenges for Science and Society David Mechanic, Ph.D. Institute for Health, Health Care Policy and Aging Research Rutgers, the State.
One starting point: Health Inequalities There are inequalities in health between countries and within countries; these are often linked to the wealth of.
Biostatistics Case Studies 2005 Peter D. Christenson Biostatistician Session 4: Taking Risks and Playing the Odds: OR vs.
Kansas Department of Health and Environment Center for Health Disparities 2008 Health Disparities Conference Topeka, Kansas, Apr. 1, 2008 Measuring Health.
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
1 Health inequalities: underlying factors and different ways of addressing them.
Conflicting Values for Evaluation: Effectiveness or Equity Louise Potvin Chair CHSRF/CIHR, Community Approaches and Health Inequalities, Université de.
Understanding Variations in Group Differences that are the Results of Variations in the Prevalence of an Outcome American Public Health Association 134.
Approaches to the measurement of excess risk 1. Ratio of RISKS 2. Difference in RISKS: –(risk in Exposed)-(risk in Non-Exposed) Risk in Exposed Risk in.
16 th Nordic Demographic Symposium Helsinki, Finland, 5-7 June 2008 Measures of Health Inequalities that are Unaffected by the Prevalence of an Outcome.
Abcd AGEING POPULATION - Burden or Benefit? Demographic Trends Adrian Gallop Edinburgh 21 January 2002.
4th June 2012 Nisha Kini Disparities in Heart Attack Knowledge by Gender, Race/Ethnicity, Education Level and Household Income among Maine adults.
Royal Statistical Society 2009 Conference Edinburgh, Scotland 7-11 September 2009 Measuring Health Inequalities by an Approach Unaffected by the Overall.
7 th International Conference on Health Policy Statistics, Philadelphia, PA, January 17-18, 2008 Can We Actually Measure Health Disparities? James P. Scanlan.
Measuring Healthcare Disparities Third North American Congress of Epidemiology Montreal, Quebec, June 21-24, 2011 James P. Scanlan Attorney at Law Washington,
British Society for Population Studies 2007 Annual Conference St. Andrews, Scotland, Sep 2007 Methodological Issue in Comparing the Size of Differences.
Very low CHD mortality among men aged in several states in the United States Akira Sekikawa, MD, PhD, PhD Lewis H Kuller, MD, DrPH Department of.
A short introduction to epidemiology Chapter 6: Precision Neil Pearce Centre for Public Health Research Massey University Wellington, New Zealand.
Methods of Presenting and Interpreting Information Class 9.
CROSS SECTIONAL STUDIES
Lecture #8 Thursday, September 15, 2016 Textbook: Section 4.4
Statistics 200 Lecture #9 Tuesday, September 20, 2016
Health Disparities and Their Public Health Solutions
Mortality: Introduction, Measurements
Kidney Transplantation and Wait-Listing Rates from the International Dialysis Outcomes and Practice Patterns Study (DOPPS)
Mesfin S. Mulatu, Ph.D., M.P.H. The MayaTech Corporation
Comparing the Burden of Disease across the Nordic countries
The Importance of Adequately Powered Studies
Italy - Evidence package
Fred Pampel University of Colorado, Boulder
Chapter 7 Sampling and Sampling Distributions
Association between GDP and old-age mortality in seven European countries, A life-course perspective F.Janssen, A.E.Kunst, J.P.Mackenbach Department.
Presentation for Session VI.
Epidemiologic Measures of Association
The Misinterpretation of Health Inequalities in the United Kingdom
The Misinterpretation of Health Inequalities in Nordic Countries
Relative Values.
Wenliang Hou and Geoffrey T. Sanzenbacher
A “Scottish effect” for health?
School Quality and the Black-White Achievement Gap
Sampling Distributions
Hypothesis Testing Review
Essential Statistics Two Categorical Variables: The Chi-Square Test
Longitudinal Designs.
Dan Goldhaber1,2, Vanessa Quince2, and Roddy Theobald1
Examples and SAS introduction: -Violations of the rare disease assumption -Use of Fisher’s exact test January 14, 2004.
Numeracy Achievement Gaps of Low- and High-Performing Adults: An Analysis Within and Across Countries David C. Miller, Ph.D. Belle Raim.
Dramatic Declines in Lifetime HIV Risk and Persistence of Racial Disparities among Men Who Have Sex with Men in King County, Washington, USA IAS 2015.
Prof. Terje A. Eikemo by Professor of sociology, NTNU, Norway
Sexually Transmitted Infections in Europe
Age and Sex structure.
Evaluating Effect Measure Modification
Psych 231: Research Methods in Psychology
James P. Scanlan Attorney at Law Washington, DC, USA
Part 3: Weighting Estimation Samples Frank Porell
Increasing Disparity: The Scanlan Effect
Module appendix - Attributable risk
EPUNET Conference in Barcelona at 9th of May 2006 Katja Forssén &
9th International Conference on Health Policy Statistics
Who’s cooking? Analysis of food preparation time in the 2003 ATUS
CROSS SECTIONAL STUDIES
Measuring Health Disparities in Healthy People 2010
Presentation transcript:

James P. Scanlan Attorney at Law Washington, DC, USA jps@jpscanlan.com British Society for Population Studies, 2008 Annual Conference University of Manchester 10-12 September 2008 An Approach to Measuring Differences between Rates that is not Affected by the Overall Prevalence of an Outcome James P. Scanlan Attorney at Law Washington, DC, USA jps@jpscanlan.com

Subjects 1. The problem with standard binary measures of differences between rates (relative differences, absolute differences, odds ratios): that all exhibit patterns of correlation with overall prevalence (i.e., among other things, they tend to change as overall prevalence changes) (BSPS 2006, 2007) 2. A plausible alternative approach that avoids the problem with standard measures: a measure that does not change as overall prevalence changes

References Measuring Health Disparities page (especially the Solutions tab) and Scanlan’s Rule page on jpscanlan.com Can We Actually Measure Health Disparities? (Chance 2006) (A12) Race and Mortality (Society 2000) (A10) The Misinterpretation of Health Inequalities in the United Kingdom (BSPS 2006) (B6) BSPS 2007 (B11)

Patterns by Which Binary Measures Tend to Change as the Overall Prevalence of an Outcome Changes – Scanlan’s Rules SR1: The rarer an outcome, the greater tends to be the relative difference in rates of experiencing it and the smaller tends to be the relative difference in rates of avoiding it (IR1 in BSPS 2006; see Bauld, Day, Judge, 2008) SR2: As an outcome changes in overall prevalence, the odds ratio tends to change in the same direction of the larger of the two relative differences and the absolute difference tends to change in the same direction as the smaller of the two relative differences ─ where numerators are reversed on the two risk ratios (see Semantic Issues tab on Scanlan’s Rule page)

Fig 1. Ratio of (1) Advantaged Group (AG) Success Rate to Disadvantaged Group (DG) Success Rate at Various Cutoffs Defined by AG Success Rate

Fig 2. Ratios of (1) AG Success Rate to DG Success Rate and (2) DG Fail Rate to AG Fail Rate

Fig 3. Ratios of (1) AG Success Rate to DG Success Rate, (2) DG Fail Rate to AG Fail Rate, and (3) DG Fail Odds to AG Fails Odds

Fig 4. Ratios of (1) AG Success Rate to DG Success Rate, (2) DG Fail Rate to AG Fail Rate, and (3) DG Fail Odds to AG Fails Odds; and Absolute Diff Between Rates

Table 1 Illustration of the Problem and Intimation of the Solution (in terms of a favorable outcome increasing in overall prevalence) Period Yr 1 Yr 2 Yr 3 Yr 4 AG Rate 40% 58% 76% 94% DG Rate 23% 39% 58% 85% Measures of Difference (Blue=decrease; Red=increase) Ratio 1 1.74 1.45 1.31 1.11 Ratio 2 1.28 1.49 1.75 2.50 Odds Ratio 2.23 2.16 2.29 2.76 Absol Diff .17 .19 .18 .09 EES (z) .50 .50 .50 .50

Estimated Effect Size (EES) Difference between means of hypothesized underlying distributions of risks of experiencing an outcome, in terms of percentage of a standard deviation, assuming normality of the distributions

Table 2 Simplified Illustration of the Solution (in terms of a favorable outcome increasing in overall prevalence) Period Yr 1 Yr 2 AG Rate 40% 58% DG Rate 23% 40% Measures of Difference Change Direction Ratio 1 1.74 1.43 Increase Ratio 2 1.28 1.45 Decrease Odds Ratio 2.23 2.07 Decrease Absol Diff .17 .18 Increase EES (z) .50 .47 Decrease

Table 3 Illustration of Meaning of Various Ratios at Different Prevalence Levels DGFailRate AGFailRate EES 1.2 60.0% 50.0% 0.26 18.4% 15.4% 0.12 1.5 75.0% 0.68 45.0% 30.0% 0.39 2.0 40.0% 20.0% 0.59 10.0% 0.44 1.0% 0.5% 0.24 2.5 24.2% 9.7% 0.60 7.4% 2.9% 3.0 44.0% 14.7% 0.90 14.4% 4.8% 2.7% 0.9%

Caveat – Compositional Differences Differences in the proportions groups being analyzed comprise of the total population in settings being compared undermine otherwise valid measurement approaches See Heller et al. (BMJ 2002), Boström and Rosén (SJPH 2003), D43 Solution seems always to compare same proportions (e.g., top vs. bottom quintile), which may often limit analyses to income Less of an issue for US racial comparisons

Table 4 Illustration Based on Morita et. al Table 4 Illustration Based on Morita et. al. (Pediatrics 2008) Data on Black and White Hepatitis B Vaccination Rates Pre and Post School-Entry Vaccination Requirement (see D52) Period Grade Year WhRt BlRt Fav Ratio Adv AbsDf EES Pre Requ 5 (Y1) 1996 8% 3% 2.67 1.05 0.05 0.47 Post (Y2) 1997 46% 33% 1.39 1.24 0.13 0.34 9 32% 1.44 1.26 0.14 0.37 89% 84% 1.06 1.45 0.24

Table 5 Illustration of UK Changes Over Time from Table 4 Table 5 Illustration of UK Changes Over Time from Table 4.13 of The Widening Gap (rates per 100,000) Cohort Year Class I Class V Mort Ratio Survival AbsDf EES 55-64 1921 2247 3061 1.36 1.008397 814 0.14 1931 2237 2535 1.13 1.003058 298 0.06 1951 2257 2523 1.12 1.002729 266 0.05 1961 1699 2912 1.71 1.012494 1213 0.25 1971 1736 2755 1.59 1.010479 1019 0.21 1981 1267 2728 2.15 1.015020 1461 0.32 1991 953 2484 2.61 1.015700 1531 0.39

Table 6 Illustration of UK Differences across Age Groups from Table 4 Table 6 Illustration of UK Differences across Age Groups from Table 4.13 of The Widening Gap Year Cohort Class I Class V Mort Ratio Survival AbsDf EES 1991 25-34 39 187 4.8 1.001483 148 0.47 35-44 101 382 3.8 1.002821 281 0.42 45-54 306 916 3.0 1.006156 610 0.39 55-64 953 2484 2.6 1.015700 1531

Table 7 Illustration of Comparisons as to Different Conditions from Lawlor (AJPH 2006) (Aberdeen 1950 birth cohort) (rates are per 10,000) (see D28) Cond Class I Class V Adv Ratio Fav AbsDf EES CHD 8.30 20.50 2.5 1.001223 12.2 0.28 Stroke 2.30 7.80 3.4 1.000550 5.5 0.34

Table 8 Illustration of Age Group Comparisons in Whitehall Studies from Marang-van de Mheen (JECH 2001) (rates are per 1,000) Age HGMR LGMR MortRatio SurvRatio AbsDf EES 55-59 6.80 13.90 2.05 1.0072001 7.1 0.27 60-64 11.30 19.90 1.76 1.0087746 8.6 0.22 65-69 17.50 28.10 1.61 1.0109065 10.6 0.20 70-74 30.90 47.50 1.54 1.0174278 16.6 75-79 50.60 70.00 1.38 1.0208602 19.4 0.16 80-84 78.30 107.60 1.0328328 29.3 0.19 85-89 144.30 181.60 1.26 1.0455767 37.3

Table 9 Illustration Based on Boström and Rosén (SJPH 2003) Data on Mortality by Occupation in Seven European Countries (see D43 caveat) Country EES 1980-84 EES 1990-94 Denmark 0.14 0.13 England and Wales 0.11 0.15 Finland 0.16 0.23 Ireland 0.10 0.19 Norway 0.12 Spain Sweden 0.17

Problems with the Solution Always practical issues (we do not really know the shape of the underlying distributions) Sometimes fundamental issues (e.g., where we know distributions are not normal because they are truncated portions of larger distributions, see D43); cf. BSPS 2007, Fig. 6 Absolute minimum issue (D43,B6)

Conclusion If we are mindful of the problems, the approach provides a framework for cautiously appraising the size of differences between rates. Regardless of problems, the approach is superior to reliance on standard binary measures of differences between rates without regard to the way those measures tend to be correlated with the overall prevalence of an outcome.

Formula to derive EES?

Example of 8 of 76,960 rows in table downloadable from jpscanlan.com EES AG Fail DG Fail 0.60 0.50399 0.72907 0.5 0.72575 0.72241 0.49601 0.71905 0.30 0.62172 0.61791 0.6141 0.61026

Supp Table 1 Illustrations Based on Escarce and McGuire (AJPH 2004) Data on White and Black Coronary Procedure Rates, 1986 and 1997 (see D48) Proc Year Wh Rt Bl Rt Fav Ratio Adv AbsDf EES Angrm (Y1) 1986 0.86% 0.43% 1.99 1.05 0.04 0.25 (Y2) 1997 2.28% 1.61% 1.42 1.09 0.07 0.14 Angpls 0.10% 0.03% 3.09 1.01 0.01 0.32 0.26% 0.16% 1.61 0.15 ArtByp 0.31% 0.08% 3.78 1.02 0.02 0.41 0.59% 2.25 1.03 0.03 0.27

Supp Table 2: Illustration Based on Hetemaa et al Supp Table 2: Illustration Based on Hetemaa et al. (JECH 2003) Data on Finnish Revascularization Rates, 1988 and 1996, by Income Group (see D21, D58) Gender Year AG RevRt LowInc Fav Ratio Adv AbsDf EES M (Y1) 1988 17.9% 8.3% 2.16 1.12 .096 0.48 (Y2) 1996 41.2% 25.4% 1.63 1.27 .159 0.44 F 10.0% 3.7% 2.70 1.07 .063 0.51 30.8% 17.1% 1.80 1.20 .137 0.45

Supp Table 3: Illustration Based on Laaksonen et al Supp Table 3: Illustration Based on Laaksonen et al. (JECH 2008) Data on Mortality Rates of Finnish Men by Owner or Renter Status (see follow-up on D43) Age OwnMort RentMort AdvRatio FavRatio EES 40–44 1.46% 4.26% 2.91 1.03 0.46 45–49 2.46% 6.04% 2.45 1.04 0.42 50–54 3.68% 9.68% 2.63 1.07 0.49 55–59 5.62% 13.09% 2.33 1.09 0.47 60–64 8.88% 19.89% 2.24 1.14 0.5 65–69 14.33% 29.38% 2.05 1.21 0.53 70–74 24.62% 41.85% 1.70 1.30 0.48 75–79 36.55% 57.75% 1.58 1.50 0.56

Supp Table 4 Illustration from Valkonen et al Supp Table 4 Illustration from Valkonen et al. (JEPH 2000) Based on All Cause Mortality in Finland for Three Time Periods Gender Period AGMort DGMort AdvRatio FavRatio EES M 1981-85 0.64% 0.96% 1.50 1.00321 0.15 1986-90 0.53% 0.93% 1.75 1.00404 0.21 1991-95 0.46% 0.85% 1.86 1.00395 0.22 F 0.29% 0.35% 1.21 1.00060 0.07 0.26% 0.36% 1.36 1.00095 0.11 0.24% 1.48 1.00113 0.14 f